WASHINGTON, DC – On Thursday, Congresswoman Carolyn B. Maloney (D-NY) officially requested that the House Committee on the Judiciary hold a hearing on the Equal Rights Amendment (ERA), which she has introduced in the last 11 Congresses. The ERA would make gender equality a constitutional guarantee and would protect women from gender-based discrimination.
In a comprehensive letter to Congresswoman Carolyn Maloney (D-NY) obtained by Yahoo Finance, SEC Chair Jay Clayton gave shareholder advocates causes for both relief and concern about whether the agency will make it harder for investors to sue public companies.
WASHINGTON, DC – Congresswoman Carolyn B. Maloney (D-NY) today wrote to Secretaries Alex Azar, Alexander Acosta and Steven Mnuchin urging them to withdraw a proposed rule from their Departments that will endanger Americans’ health.
WASHINGTON, DC – Representatives Carolyn B. Maloney (D-NY), Jerrold Nadler (D-NY), and Peter King (R-NY) this week appealed to FTC Acting Chair Maureen K. Ohlhausen to open a formal investigation into reports that individuals are impersonating September 11th Victim Compensation Fund (VCF) professionals to steal first responders’ and survivors’ information.
Three New York congressional representatives have asking the Federal Trade Commission to investigate reports that scammers are posing as Sept. 11 Victim Compensation Fund staffers to get first responders' and survivors' personal information.
First responders left sickened by the toxic fumes they inhaled at Ground Zero are now falling prey to something else — scam artists, the Daily News has learned.
A crew of callous cons have been reaching out to sufferers from 9/11-related illnesses, claiming to be members of the federal September 11th Victim Compensation Fund.
NEW YORK—On Friday, April 20th, Congresswoman Carolyn B. Maloney (NY-12) released the following statement in reaction to the news that the ‘Fearless Girl’ statue will move to a new location in front of the New York Stock Exchange:
WASHINGTON, DC – Congresswoman Carolyn B. Maloney (D-NY) sent a letter Thursday formally requesting that the Joint Economic Committee hold a hearing anti-competitive practices in the prescription drug market.